Company / EPS (Basic)
Teladoc Health, Inc. EPS (Basic) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$1.34
FY2025
5-year range
-$84.60 / -$1.34
FY2021-FY2025
Trend
+98.4%
vs FY2024
Sector context
#131 of 160
Health Care
What the data says
Teladoc Health, Inc.'s eps (basic) of $-1.34 is lower than 82% of companies in the Health Care sector (FY2025). EPS (Basic) has fluctuated over the past 7 years, ranging from $-84.60 in FY2024 to $-1.34 in FY2025.
Based on SEC 10-K filings.
-1.34 in FY2025.
Improved from $-2.73 to $-1.34 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 160This company -$1.34 Sector average $1.67
▼
-180.1% below sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 98.4% year-over-year.
- Ranks #131 out of 160 companies in the Health Care sector.
- Lowest eps (basic) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.34 | +98.4% |
| FY2024 | -$84.60 | -2998.9% |
| FY2023 | -$2.73 | +49.1% |
| FY2022 | -$5.36 | -96.3% |
| FY2021 | -$2.73 | +49.1% |
| FY2020 | -$5.36 | -288.4% |
| FY2019 | -$1.38 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026